Pramudita, A., Rumende, C. M., & Findyartini, A. (2017). Fixed-dose combination antituberculosis therapy as a risk factor for tuberculosis recurrence: An evidence-based case report. Interna Publishing.
Chicago-viite (17. p.)Pramudita, Arvin, Cleopas M. Rumende, ja Ardi Findyartini. Fixed-dose Combination Antituberculosis Therapy as a Risk Factor for Tuberculosis Recurrence: An Evidence-based Case Report. Interna Publishing, 2017.
MLA-viite (9. p.)Pramudita, Arvin, et al. Fixed-dose Combination Antituberculosis Therapy as a Risk Factor for Tuberculosis Recurrence: An Evidence-based Case Report. Interna Publishing, 2017.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.